Investigation of drug evaluation model using Patient-Derived Cells (PDC)

被引：0
|
作者：
Moriguchi, Misato [1 ]
Tsunesumi, Shinichiro [1 ]
Enoki, Shigenori [1 ]
Katayama, Seiichi [1 ]
Chiwaki, Fumiko [2 ]
Sasaki, Hiroki [2 ]
机构：
[1] LSIM Safety Inst, Dept Pharmacol, Kamisu, Japan
[2] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3017
引用
收藏
页码：1840 / 1840
页数：1
相关论文
共 50 条
  • [21] Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells
    Kettunen, Kimmo
    Bostrom, Peter J.
    Lamminen, Tarja
    Heinosalo, Taija
    West, Gun
    Saarinen, Irena
    Kaipio, Katja
    Rantala, Juha
    Albanese, Chris
    Poutanen, Matti
    Taimen, Pekka
    EUROPEAN UROLOGY, 2019, 76 (04) : 430 - 434
  • [22] Drug discovery for osteogenesis imperfecta using patient-derived induced pluoripotent stem cells(iPSCs)
    Ma, Jingchun
    Kawai, Shunsuke
    Nishio, Megumi
    Nagata, Sanae
    Ota, Akira
    Toguchida, Junya
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 74 - 74
  • [23] Miniaturized Drug Sensitivity and Resistance Test on Patient-Derived Cells Using Droplet-Microarray
    Popova, Anna A.
    Dietrich, Sascha
    Huber, Wolfgang
    Reischl, Markus
    Peravali, Ravindra
    Levkin, Pavel A.
    SLAS TECHNOLOGY, 2021, 26 (03): : 274 - 286
  • [24] Patient-derived stem cells: pathways to drug discovery for brain diseases
    Mackay-Sim, Alan
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [25] PATIENT-DERIVED CELLS FOR EX VIVO DRUG SCREENING STUDIES OF GLIOMAS
    El-Heliebi, Amin
    Urbanic-Purkart, Tadeja
    Mahdy-Ali, Kariem
    Skofler, Christina
    Gerlitz, Lisa
    Stanzer, Stefanie
    Franz, Joakim
    Harbusch, Nora
    Madl, Tobias
    Widhalm, Georg
    Rossler, Karl
    Tomberger, Martina
    Mattersdorfer, Karin
    Kroneis, Thomas
    Oberhuber, Monika
    Pieber, Thomas
    Prietl, Barbara
    NEURO-ONCOLOGY, 2022, 24 : 209 - 209
  • [26] Predictive Drug Sensitivity Testing with Patient-Derived Cultured Leukemia Cells
    Ancheta, Richard Gopez
    Burian, Carol
    Miller, William E.
    Finlay, Darren
    Vuori, Kristiina
    Paternostro, Giovanni
    Mason, James
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S196 - S197
  • [27] Exploring Synthetic Lethality and novel drug combinations in Patient-Derived Cells
    Duleba, M.
    Zimolag, E.
    Szuszkiewicz, J.
    Serocki, M.
    Krawczyk, J.
    Bryzghalov, O.
    Stachowicz, A.
    Wieckowska, I.
    Chmiel, M.
    Kurzejamski, A.
    Lipert, B.
    Wojtowicz, K.
    Chronowski, M.
    Otrocka, M.
    Mikula, M.
    Dziadziuszko, R.
    Brzozka, K.
    Rzymski, T.
    Mazan, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S156 - S156
  • [28] In silico modeling predicts drug sensitivity of patient-derived cancer cells
    Sandeep C Pingle
    Zeba Sultana
    Sandra Pastorino
    Pengfei Jiang
    Rajesh Mukthavaram
    Ying Chao
    Ila Sri Bharati
    Natsuko Nomura
    Milan Makale
    Taher Abbasi
    Shweta Kapoor
    Ansu Kumar
    Shahabuddin Usmani
    Ashish Agrawal
    Shireen Vali
    Santosh Kesari
    Journal of Translational Medicine, 12
  • [29] Using patient-derived induced pluripotent stem cells to model multiple epiphyseal dysplasia
    Woods, S.
    Harley, P.
    Soul, J.
    Kamprom, N.
    Bates, N.
    Wang, Q.
    Mortier, G.
    Hardingham, T.
    Kimber, S. J.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2018, 99 (06) : A52 - A52
  • [30] Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
    Shoda, Hirofumi
    Natsumoto, Bunki
    Fujio, Keishi
    INFLAMMATION AND REGENERATION, 2023, 43 (01)
12345